A woman recounts how a popular weekly weight-loss injection failed to deliver lasting results, and how a later diagnosis of ADHD and treatment with bupropion, along with dietary changes, produced significant and sustained weight loss.
Many people looking for a solution to weight gain try diets, exercise plans and medical treatments without understanding underlying causes. This article follows the experience of a 41-year-old woman who initially turned to a weekly weight-loss injection with hopes of ending decades of struggle, only to find a lasting answer after being diagnosed with attention-deficit hyperactivity disorder (ADHD).
Her story highlights connections between neurological conditions, reward pathways and eating behaviour.
What began as repeated dieting and attempts to curb compulsive snacking eventually led her to medical treatments. When the first option failed to work, a psychological evaluation provided a new diagnosis and a different path forward.
The narrative illuminates why some interventions may not work until the root cause is recognised and treated.
Early struggles and a disappointing medical approach
As a child she faced relentless teasing about her weight, which shaped her self-image into adulthood.
Despite trying numerous diets and exercise regimes, she found herself returning to the same patterns—especially mindless snacking on chocolate and biscuits. After a stressful period marked by a difficult divorce and prolonged unhealthy eating, she reached her highest weight and decided to try a prescription injection designed to suppress appetite.
The weekly injection she chose is known to reduce hunger for many users and can produce significant weight loss for some. She paid for the treatment out of pocket, hoping the jab would be the turning point. Over several months the drug produced only modest results—less than 11 pounds lost—and, after discontinuing treatment because of cost and limited benefit, her weight returned to the previous high.
Discovering ADHD and reframing the problem
Feeling that something else was at play, she sought help from a psychologist after years of mental health challenges and difficulty concentrating. The assessment identified ADHD, a condition described by inattentiveness, hyperactivity and impulsiveness. While ADHD affects millions, including a large number of adults, many women are diagnosed later in life because their symptoms can be overlooked or misattributed.
Research indicates a notable association between ADHD and obesity: people with ADHD face higher odds of being overweight or obese compared with the general population. Experts point to overlapping mechanisms such as differences in the brain’s reward system—particularly levels of the neurotransmitter dopamine—which can make immediate rewards like palatable food especially appealing.
Why dopamine matters
In people with ADHD, lower baseline dopamine may make everyday activities less gratifying. To compensate, some turn to behaviours that rapidly increase dopamine, such as eating sugary or highly processed foods. This pattern—sometimes called “dopamine snacking”—can fuel cycles of compulsive eating even when someone consciously wants to stop.
Treatment, behavioural shifts and sustained results
Following her diagnosis, the psychologist prescribed a daily medication that can elevate dopamine levels and is used for ADHD and depression. Within weeks she noticed a reduction in impulsive snacking: the automatic urge to reach for sweets eased, and she gained a brief pause in the moment of temptation, enough to choose otherwise.
Alongside the medication, she made dietary adjustments—swapping croissants and ham-and-cheese toasties for soups and salads—and reports that she felt more capable of making deliberate food choices rather than acting on impulse. Clinicians note that some ADHD medications can also suppress appetite, which may contribute to weight loss, but in her case the critical change was increased control over impulsive behaviour.
Outcomes and reflection
Since starting the ADHD medication about a year ago, she lost more than three stone and reached a healthy, stable weight. Beyond the physical change, she now understands her past struggles differently: behaviours that were once framed as personal failings had a medical explanation. This reframing has brought emotional relief and a new perspective on how many women might be living with undiagnosed ADHD.
Her experience underscores several broader points: first, that not all weight problems respond to the same interventions; second, that mental health and neurological diagnoses can be integral to treating obesity; and third, that combining medical treatment with dietary behaviour change can produce durable outcomes. For clinicians and patients alike, the case suggests value in considering neurodevelopmental conditions when weight management repeatedly fails.
While individual results vary and any medication should be prescribed and monitored by a clinician, her story is a reminder that identifying an untreated condition—such as ADHD—can sometimes unlock progress that earlier treatments did not achieve. Awareness and timely assessment may help others find more effective, sustainable strategies for weight and wellbeing.
